Wayland Rushing

Director, Scientific Affairs at Eurofins BioPharma Product Testing

Dr. Wayland Rushing has 20 years of CMC analytical testing experience, including over 15 years of experience in testing of inhalation drug products.

As the Director of Scientific Affairs he is responsible for designing and implementing CMC testing programs for Eurofins clients, including programs for pMDI’s, DPI’s, Nebulizers, pre-filled syringes along with a variety of other drug delivery and container/closure systems.

He earned his bachelor’s degree from Westminster College and his Ph.D. in Chemistry from the University of Missouri.

Wayland_Rushing_Eurofins_BioTech_Pharma_Summit_IRDD_Inhalation_Respiratory_Drug_Delivery_New_York

Title: Analytical Challenges in Implementing Effective QC/Stability Testing of Inhalation Drug Products

  • Technical challenges of moving from R&D to QC testing for product specific tests (DSD, CU, Spray pattern, etc)
  • Automated versus manual testing
  • Extractables and Leachables regulatory requirements